CPC860 (PHENAZOPYRIDINE 200 mg)

Pill imprint CPC860 has been identified as Phenazopyridine hydrochloride 200 mg.

Phenazopyridine is used in the treatment of interstitial cystitis; dysuria and belongs to the drug class miscellaneous genitourinary tract agents. There is no proven risk in humans during pregnancy. Phenazopyridine 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for CPC860

Phenazopyridine hydrochloride 200 mg CPC860  Front
Phenazopyridine hydrochloride 200 mg CPC860  Back
Phenazopyridine hydrochloride
Imprint:
CPC860
Strength:
200 mg
Color:
Red
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Miscellaneous genitourinary tract agents
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC):
51991-0525
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
10267-0860 Contract Pharmacal Corporation
64376-0812 Boca Pharmacal Inc
00430-0191 Warner Chilcott
54569-0197 A S Medication Solutions LLC (repackager)
21695-0301 Rebel Distributors Corp (repackager)
66336-0105 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)